Tam JS - Search Results

1

Does hepatitis C virus infection contribute to hepatocellular carcinoma in Hong Kong?

Leung NW, Tam JS, Lai JY, Leung TW, Lau WY, Shiu W, Li AK. Leung NW, et al. Among authors: tam js. Cancer. 1992 Jul 1;70(1):40-4. doi: 10.1002/1097-0142(19920701)70:1<40::aid-cncr2820700107>3.0.co;2-p. Cancer. 1992. PMID: 1318777

2

Viral hepatitis C in Hong Kong.

Leung N, Chu C, Tam JS. Leung N, et al. Among authors: tam js. Intervirology. 2006;49(1-2):23-7. doi: 10.1159/000087259. Intervirology. 2006. PMID: 16166785

3

Prevalence of antibody to hepatitis C virus in HBsAg-negative chronic liver disease in Hong Kong using different assays.

Lai JY, Tam JS, Lam LY, Leung NW. Lai JY, et al. Among authors: tam js. J Med Virol. 1992 Jun;37(2):158-60. doi: 10.1002/jmv.1890370215. J Med Virol. 1992. PMID: 1321225

4

Hepatitis with isolated serum antibody to hepatitis B core antigen. A variant of non-A, non-B hepatitis?

Lai KN, Lai FM, Leung NW, Lo ST, Tam JS. Lai KN, et al. Among authors: tam js. Am J Clin Pathol. 1990 Jan;93(1):79-83. doi: 10.1093/ajcp/93.1.79. Am J Clin Pathol. 1990. PMID: 2104740

5

T lymphocyte activation in chronic hepatitis B infection: interleukin 2 release and its receptor expression.

Lai KN, Leung JC, Tam JS, Leung NW. Lai KN, et al. Among authors: tam js. Am J Gastroenterol. 1989 Dec;84(12):1532-7. Am J Gastroenterol. 1989. PMID: 2596455

6

Hepatitis B virus DNA in peripheral blood leukocytes. A comparison between hepatocellular carcinoma and other hepatitis B virus-related chronic liver diseases.

Leung NW, Tam JS, Lau GT, Leung TW, Lau WY, Li AK. Leung NW, et al. Among authors: tam js. Cancer. 1994 Feb 15;73(4):1143-8. doi: 10.1002/1097-0142(19940215)73:4<1143::aid-cncr2820730404>3.0.co;2-u. Cancer. 1994. PMID: 8313316

7

Relationship of clinical and virological factors with hepatitis activity in hepatitis B e antigen-negative chronic hepatitis B virus-infected patients.

Sung JJ, Chan HL, Wong ML, Tse CH, Yuen SC, Tam JS, Leung NW. Sung JJ, et al. Among authors: tam js. J Viral Hepat. 2002 May;9(3):229-34. doi: 10.1046/j.1365-2893.2002.00352.x. J Viral Hepat. 2002. PMID: 12010512

8

Effects of alpha-interferon and prednisone on serum-soluble interleukin-2 receptor (sIL-2R) in chronic hepatitis B infection.

Leung NW, Leung JC, Tam JS, Lau JT, Lai KN. Leung NW, et al. Among authors: tam js. Am J Gastroenterol. 1992 Jan;87(1):113-7. Am J Gastroenterol. 1992. PMID: 1728107

9

Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy.

Yeo W, Steinberg JL, Tam JS, Chan PK, Leung NW, Lam KC, Mok TS, Johnson PJ. Yeo W, et al. Among authors: tam js. J Med Virol. 1999 Nov;59(3):263-9. doi: 10.1002/(sici)1096-9071(199911)59:3<263::aid-jmv1>3.0.co;2-x. J Med Virol. 1999. PMID: 10502254

10

Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role.

Steinberg JL, Yeo W, Zhong S, Chan JY, Tam JS, Chan PK, Leung NW, Johnson PJ. Steinberg JL, et al. Among authors: tam js. J Med Virol. 2000 Mar;60(3):249-55. J Med Virol. 2000. PMID: 10630955

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

198 results

Search Page

Filters